Clinical Trial: First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis

U.S., April 15 -- ClinicalTrials.gov registry received information related to the study (NCT07527923) titled 'First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis' on April 07.

Brief Summary: This clinical trial will evaluate REGN20423, an investigational medicine that has not previously been studied in humans and is used only in clinical studies. The study will assess the safety, how the body processes the medicine, and the dose levels that may work best. It will also test whether REGN20423 can help treat adults with atopic dermatitis.

This is a two-part study:

Part A includes healthy adult participants. Part B includes adults with atopic dermatitis.

The Study is Looking a...